TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 187 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $101,000 | -55.3% | 10,400 | -50.6% | 0.00% | – |
| Q1 2021 | $226,000 | -66.5% | 21,050 | -54.0% | 0.00% | -100.0% |
| Q4 2020 | $674,000 | +155.3% | 45,808 | +146.3% | 0.00% | 0.0% |
| Q3 2020 | $264,000 | +166.7% | 18,596 | +52.1% | 0.00% | – |
| Q2 2020 | $99,000 | -41.8% | 12,225 | -58.3% | 0.00% | -100.0% |
| Q3 2018 | $170,000 | -3.4% | 29,300 | -0.3% | 0.00% | 0.0% |
| Q2 2018 | $176,000 | -13.7% | 29,400 | +3.5% | 0.00% | 0.0% |
| Q1 2018 | $204,000 | +6.8% | 28,400 | +7.6% | 0.00% | 0.0% |
| Q4 2017 | $191,000 | +40.4% | 26,400 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $136,000 | +17.2% | 26,400 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $116,000 | -28.0% | 26,400 | +1.1% | 0.00% | 0.0% |
| Q1 2017 | $161,000 | +9.5% | 26,100 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $147,000 | +22.5% | 26,100 | +222.2% | 0.00% | 0.0% |
| Q3 2016 | $120,000 | +126.4% | 8,100 | +37.3% | 0.00% | – |
| Q2 2016 | $53,000 | +5200.0% | 5,900 | +5800.0% | 0.00% | – |
| Q1 2016 | $1,000 | 0.0% | 100 | 0.0% | 0.00% | – |
| Q4 2015 | $1,000 | -99.2% | 100 | -98.9% | 0.00% | -100.0% |
| Q3 2015 | $124,000 | – | 9,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|